Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzyme cleavable linker mediated effective intracellular delivery of siRNA
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzyme cleavable linker mediated effective intracellular delivery of siRNA
Authors
Keywords
siRNA delivery, Cell penetrating peptide, Low molecular weight protamine, Antibody, Enzyme activatable
Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 606, Issue -, Pages 120940
Publisher
Elsevier BV
Online
2021-07-24
DOI
10.1016/j.ijpharm.2021.120940
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanotherapeutics for Gene Modulation that Prevents Apoptosis in the Brain and Fatal Neuroinflammation
- (2018) Sang-Soo Kim et al. MOLECULAR THERAPY
- Improved method for synthesis of low molecular weight protamine–siRNA conjugate
- (2018) Zhili Yu et al. Acta Pharmaceutica Sinica B
- High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA
- (2017) Junxiao Ye et al. Theranostics
- RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?
- (2016) Maggie L. Bobbin et al. Annual Review of Pharmacology and Toxicology
- Redox-responsive, reversibly-crosslinked thiolated cationic helical polypeptides for efficient siRNA encapsulation and delivery
- (2015) Nan Zheng et al. JOURNAL OF CONTROLLED RELEASE
- 15 years of ATTEMPTS: A macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting
- (2015) Junxiao Ye et al. JOURNAL OF CONTROLLED RELEASE
- Antibody-coupled siRNA as an efficient method for in vivo mRNA knockdown
- (2015) Nicole Bäumer et al. Nature Protocols
- Clinical experiences with systemically administered siRNA-based therapeutics in cancer
- (2015) Jonathan E. Zuckerman et al. NATURE REVIEWS DRUG DISCOVERY
- A Prodrug-type, MMP-2-targeting Nanoprobe for Tumor Detection and Imaging
- (2015) Yaping Wang et al. Theranostics
- Molecular Parameters of siRNA–Cell Penetrating Peptide Nanocomplexes for Efficient Cellular Delivery
- (2013) Alexander H. van Asbeck et al. ACS Nano
- Curb challenges of the “Trojan Horse” approach: Smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery
- (2013) Yongzhuo Huang et al. ADVANCED DRUG DELIVERY REVIEWS
- The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption
- (2013) Huining He et al. BIOMATERIALS
- Core-Shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery
- (2013) Ling-Yan Gao et al. BIOMATERIALS
- Effects of legumain as a potential prognostic factor on gastric cancers
- (2013) Na Li et al. MEDICAL ONCOLOGY
- Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
- (2013) Jerome Gilleron et al. NATURE BIOTECHNOLOGY
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- Nuclear Legumain Activity in Colorectal Cancer
- (2013) Mads H. Haugen et al. PLoS One
- Alginic Acid-Coated Chitosan Nanoparticles Loaded with Legumain DNA Vaccine: Effect against Breast Cancer in Mice
- (2013) Ze Liu et al. PLoS One
- Targeting Androgen Receptor/Src Complex Impairs the Aggressive Phenotype of Human Fibrosarcoma Cells
- (2013) Gabriella Castoria et al. PLoS One
- Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging
- (2012) Mya S Thu et al. NATURE MEDICINE
- Multivalent Cyclic RGD Conjugates for Targeted Delivery of Small Interfering RNA
- (2011) Md. Rowshon Alam et al. BIOCONJUGATE CHEMISTRY
- Immobilized thermolysin for highly efficient production of low-molecular-weight protamine-An attractive cell-penetrating peptide for macromolecular drug delivery applications
- (2011) Allan E. David et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity
- (2011) Debbie Liao et al. Nanomedicine-Nanotechnology Biology and Medicine
- Off-Target Lapatinib Activity Sensitizes Colon Cancer Cells Through TRAIL Death Receptor Up-Regulation
- (2011) N. G. Dolloff et al. Science Translational Medicine
- Delivery of siRNA Therapeutics: Barriers and Carriers
- (2010) Jie Wang et al. AAPS Journal
- Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon
- (2010) Hamed Laroui et al. BIOMATERIALS
- A Novel Antitumor Prodrug Platform Designed to Be Cleaved by the Endoprotease Legumain
- (2009) Liron Stern et al. BIOCONJUGATE CHEMISTRY
- Recent advances in quantitative colocalization analysis: Focus on neuroscience
- (2009) Vadim Zinchuk et al. PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY
- Epidermal Growth Factor Receptor Blockade in Combination with Conventional Chemotherapy Inhibits Soft Tissue Sarcoma Cell Growth In vitro and In vivo
- (2008) W. Ren et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now